BioSpace News Archive

Improvements to large diameter devices include accessiblity through smaller sheaths while providing enhanced visualization under fluoroscopy

Naviswiss US announced the first successful U.S. surgery with its hand-held hip navigation system in New York City, NY. Dr. Alejandro Della Valle performed the procedure using the imageless system and accurately placing implants during a total hip replacement.

Pioneer in Virtual Musculoskeletal Pain Programs Welcomes Shaheen E Lakhan, MD, PhD, FAAN as Head of Clinical; Also Adds Patrick Conroy as Head of Engineering.

PDI, a global leader in infection prevention product and service solutions, today announced the appointment of Michael Yang, Ph.D., as Senior Vice President of Research and Development (R&D).

Aphex BioCleanse Systems, Inc. (OTC: SNST) (“Aphex” or “the Company”), a sanitization solutions company focused on the development and distribution of chemical-free, water-based sanitization and disinfection products, announced today that the Company has appointed CMW Media, a creative and public relations agency specializing in emerging markets, as its strategic communications firm.

Cloud DX, a leading provider of virtual care and remote patient monitoring solutions, today announced the U.S. launch of its updated Connected Health Kit, alongside a new quick-start program enabling health providers and care teams to quickly and cost-effectively expand remote patient monitoring during the COVID-19 pandemic.

VivaLNK, a leading provider of connected healthcare devices, announces that the University of California, San Francisco (UCSF) will be utilizing its continuous wearable ECG sensor for a 3,000 subject multi-year study on atrial fibrillation (AF).

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, announced Frederic Vanderhaegen has been appointed Executive Vice President, Americas and Europe, effective immediately.

Genosity, Inc., an innovative biotechnology company that provides comprehensive software and technical solutions to enable precision medicine announced today that it has entered into a strategic collaboration with Personal Genome Diagnostics Inc. (PGDx), one of the leading companies in cancer genomics, that recently received market clearance from the U.S. Food and Drug Administration (FDA) for PGDx elio™ tissue complete

Aphena Pharma Solutions announces a $21 million expansion of its Solid Dose Division in Cookeville, Tennessee, with the acquisition of a 500,000-square-foot property, purpose-built for FDA manufacturing and packaging operations.